Anti‐Interleukin Therapy in Asthma

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|97|1|55-65

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.97, Iss.1, 2015-01, pp. : 55-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

No Effect of Anti-Interleukin-5 Therapy (Mepolizumab) on the Atopy Patch Test in Atopic Dermatitis Patients

By  

International Archives of Allergy and Immunology, Vol. 141, Iss. 3, 2006-10 ,pp. : 290-294

Karger

Access to resources Recommend Favorite

Successful Treatment of Autoimmune Hemolytic Anemia Associated with Multicentric Castleman Disease by Anti-Interleukin-6 Receptor Antibody (Tocilizumab) Therapy

By  

Acta Haematologica, Vol. 126, Iss. 3, 2011-07 ,pp. : 147-150

Karger

Access to resources Recommend Favorite

Anti‐interleukin‐6 signalling therapy rebalances the disrupted cytokine production of B cells from patients with active rheumatoid arthritis

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 48, Iss. 1, 2018-01 ,pp. : 194-203

John Wiley & Sons Inc

Access to resources Recommend Favorite

Brief Report: Leucine‐Rich α2‐Glycoprotein as a Potential Biomarker for Joint Inflammation During Anti–Interleukin‐6 Biologic Therapy in Rheumatoid Arthritis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 8, 2015-05 ,pp. : 2056-2060

John Wiley & Sons Inc

Access to resources Recommend Favorite

Plasmablastic microlymphoma arising in human herpesvirus‐8‐associated multicentric Castleman disease in a human immunodeficiency virus‐seronegative patient with clinical response to anti‐interleukin‐6 therapy

By  

HISTOPATHOLOGY, Vol. 67, Iss. 6, 2015-12 ,pp. : 930-932

John Wiley & Sons Inc

Access to resources Recommend Favorite